Dublin, Feb. 14, 2017 -- Research and Markets has announced the addition of the "Cholera Forecast for selected Asian Markets 2017-2027" report to their offering.
Cholera is a bacterial disease caused by infection from Vibrio cholerae species (O1, O139), usually spread through contaminated water. Cholera causes severe diarrhoea and dehydration. Left untreated, cholera can be fatal in a matter of hours, even in previously healthy people.
This report provides the current incidence population for Cholera for Selected Asian Markets (Cambodia, Indonesia, Lao PDR, and Vietnam) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms of Cholera have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Risk factors for contracting cholera relate mostly to contaminated water and sanitation. The disease shows marked seasonality in developing nations, and outbreaks can occur during natural disasters (tsunamis) and complex emergencies (generally affecting the water supply / sanitation infrastructure).
This report is built using data and information sourced from the proprietary patient segmentation database. To generate accurate patient population estimates, the database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography
6. Disease Prognosis & Clinical Course
7. Methodology for quantification of patient numbers
8. Top-line estimated incidence for Cholera
9. Cholera in Vietnam
10. Abbreviations used in the report
11. Patient-Based Offering
12. Online Pricing Data and Platforms
13. References
14. Appendix
For more information about this report visit http://www.researchandmarkets.com/research/vh5jzd/cholera_forecast
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs


Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 



